Drugs / FK788
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00047814 | Oct 2002 → Mar 2006 | hepatitis C virus infection | Astellas Pharma Inc | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FK788 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00047814 ↗ |